Is this little-known, gluten-free seed the ultimate superfood for lowering cholesterol and losing weight?
iStock Amaranth, an ancient pseudocereal rich in calcium, iron, protein, and fiber, is gaining recognition for its impressive health benefits. Studies show it supports bone strength, lowers bad cholesterol, aids digestion, fights inflammation, and helps regulate blood sugar. (Representational Image: iStock) In the quest for better health, one humble seed is attracting growing attention from scientists and nutritionists alike. Amaranth, a pseudocereal revered by ancient Aztecs, is fast emerging as a powerhouse ingredient capable of strengthening bones, cutting cholesterol, and aiding weight management. But what makes this ancient grain so remarkable? According to a report from The Mirror , amaranth isn't your typical cereal grain. Classified as a pseudocereal, it is a non-grass plant consumed much like true cereals but uniquely gluten-free. Dr. Julieta M. Lopez-Martinez highlights that amaranth is rich in calcium and iron, essential minerals that support bone strength and may even help prevent cellular changes linked to tumor development. A study from Vienna's BOKU-University further praises amaranth as 'one of the most promising food plant genera,' thanks to its high-quality protein, unsaturated oils, fiber, and essential minerals.
— Farmsent_io (@Farmsent_io)
Dr. Josh Axe, a clinical nutritionist, explains that amaranth encompasses over 60 species and was once a staple food for the Aztecs. From its leaves used medicinally to its grain serving as a fiber-rich protein source and oil applied for skin health, amaranth offers diverse benefits. Its complete protein content carries anti-inflammatory and antioxidant properties, making it an ideal addition to combat heart disease, digestive issues, and chronic inflammation. Calcium is critical for bone repair and strength, and amaranth provides a significant dose. Dr. Axe emphasizes that adequate calcium intake can reduce the risk of fractures and osteoporosis, a condition marked by weakened bones. Regular consumption of amaranth supports skeletal health, helping maintain mobility and physical activity, especially important as we age. Amaranth's fiber content plays a key role in managing cholesterol and improving digestion. Research published in the International Journal for Vitamin and Nutrition Research found amaranth could lower harmful LDL cholesterol by up to 50%. Its mix of insoluble and soluble fibers traps fats and toxins in the digestive tract, facilitating their elimination and promoting gut health. Scientists at Purdue University confirm that amaranth contains a higher proportion of soluble fiber than wheat or maize, enhancing its digestive benefits.
One cup of amaranth delivers more than the recommended daily manganese, a mineral vital in regulating blood sugar through gluconeogenesis—the process of converting protein into glucose. Studies indicate that manganese deficiency may impair glucose balance and kidney function, highlighting amaranth's role in diabetes management. Its rich protein and fiber content also promote satiety, reducing overeating and supporting weight loss. By keeping digestion regular and inflammation at bay, amaranth helps maintain a healthy metabolism and physical activity levels, both crucial for sustainable weight control. From ancient times to today's nutritional science, amaranth has proven itself a versatile, nutrient-dense food with far-reaching health benefits. Whether you incorporate it as flour, grain, leaf, or oil, this seed offers a natural, powerful boost to bone health, cholesterol management, diabetes control, and weight loss efforts. With science backing its myriad benefits, amaranth might just be the secret weapon your diet needs for a stronger, healthier body.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
8 hours ago
- Economic Times
Want to live longer? Forget expensive experiments; longevity doctor reveals simple secrets to a healthier, happier life
Longevity doctor Dr. Avinish Reddy believes living a longer, healthier life is rooted in simple, consistent habits. From daily strength and cardio workouts to prioritizing social connections and brain health, his approach avoids extremes. (Images: LinkedIn/Avinish Reddy, iStock) In a world obsessed with stories of Bryan Johnson's biohacking with high-tech health fixes, Dr. Avinish Reddy is bringing longevity back to the basics. His message is refreshingly clear: living a long, healthy life doesn't have to be complicated. After years of studying under world-renowned longevity expert Dr. Peter Attia and launching his own practice, Elevated Medical, in July 2024, Dr. Reddy has distilled the science of longevity into an accessible, holistic routine—one he practices daily. According to a report from CNBC Make It , with a framework that spans medicine, exercise, nutrition, and lifestyle, Dr. Reddy's philosophy is grounded in structure, consistency, and self-awareness rather than fads or extreme measures. His methods are not just for patients—they are part of his own lived experience. At the heart of Dr. Reddy's approach is movement. He splits his weekly workouts evenly between strength and cardiovascular training, not just for muscle or aesthetics but to boost VO₂ Max—an often-overlooked metric linked to better health span and life span. His cardio routine includes both low-intensity endurance and high-intensity intervals, a strategy shown to be deeply effective for heart and brain health. But fitness is only one piece. Reddy also prioritizes brain health through a regimen of omega-3s and B vitamins, while engaging in mentally stimulating activities like racket sports. Table tennis, pickleball, and tennis aren't just hobbies—they're preventive tools in his longevity arsenal. Eventually, he plans to learn a language or an instrument, tapping into deeper neuroplastic benefits. While many obsess over diet and sleep trackers, Reddy emphasizes something most wellness plans overlook: social connection. Citing the long-running Harvard study on happiness, he underscores that strong relationships—whether daily calls to his parents or reconnecting with old friends—are just as critical to longevity as exercise and nutrition. He also encourages community-based activities, like joining a local sports league, as a way to merge social bonding with physical activity. His patients, especially older ones, often seek recovery not to hit the gym again but to return to the social joys of golf groups or pickleball teams. That, he says, is the real magic. When it comes to food, Reddy believes less in chasing macros and more in correcting personal nutritional blind spots. For him, it's all about vegetables—making sure they're on his plate at every meal. He even uses a continuous glucose monitor annually to identify hidden dietary culprits that might spike his blood sugar. And perhaps most surprising for a longevity doctor, his favorite book isn't about health—it's Die With Zero by Bill Perkins. It's a manifesto for living fully, not just longer. 'Longevity shouldn't come at the cost of living,' Reddy reflects. 'What's the point of making it to 100 if you never made the memories?' Dr. Reddy's life is a masterclass in sustainable living—not by perfection, but by thoughtful, balanced habits. His philosophy pushes back against extreme health culture. It's not about chasing the next miracle cure; it's about doing the basics well, every single day. For anyone overwhelmed by the noise of the wellness industry, his message is a breath of fresh air: longevity isn't about making things harder—it's about living smarter.
Pink Villa
9 hours ago
- Pink Villa
Meghan Markle's Dad Thomas 'Struggles' Abroad as Daughter Fights Royals and Builds Empire, Know Where He's Staying
Meghan Markle's estranged father, Thomas Markle, is reportedly finding it difficult to adjust to his new life in the Philippines. The retired TV lighting director relocated to Cebu Island earlier this year, moving from his longtime home in Rosarito, Mexico, near the US border. His son, Thomas Markle Jr., also moved with him. The decision to move was part of Thomas Sr.'s effort to begin a new chapter in a more peaceful and affordable environment. He initially stayed at a 3-star hotel before settling into a USD 670-per-month high-rise apartment on the island. But the transition hasn't been easy. A source told The New York Post, 'Thomas and his son took the plunge and moved to Southeast Asia. It's been hard but they have each other.' Locals say the hot and humid climate in Cebu has taken a toll on Thomas Sr.'s health. With summer temperatures ranging from 80 to 100 degrees and humidity reaching 90%, the adjustment has been physically demanding. 'There are only two types of weather in Cebu: hot and humid, and hot and humid and raining,' a source told The Mirror. 'It's brutal even for men half his age, but it's still sad to see him looking as though he's struggling.' The Emmy award-winning lighting director has reportedly been using a cane to walk on Cebu's uneven streets. Why did Thomas Markle move to the Philippines? Before the move, Thomas Markle shared that he wanted to live in a calmer setting. In an interview with the Daily Mail in January, he said he was ready for a change, sharing that he had felt stuck in a rut and wanted to meet new people and experience kindness. He described Southeast Asia as a place full of culture and beauty. He also mentioned that he wasn't running away but was looking for a more positive life. Speaking about his daughter, he said he saw news about Meghan every day but held no ill will toward her. Thomas Markle has not spoken to Meghan Markle since before her 2018 wedding to Prince Harry. Their strained relationship worsened after his stroke in 2022. He has never met his grandchildren, Archie or Lilibet, who turned 4 on June 4.
Time of India
10 hours ago
- Time of India
A common drug shows promise for patients with liver disease
A recent Chinese clinical trial published in The BMJ reveals that dapagliflozin, a type 2 diabetes drug, shows promise in treating severe liver conditions like MASH and liver fibrosis. The study, involving 154 participants, demonstrated significant improvements in MASH and fibrosis among those receiving dapagliflozin compared to the placebo group, suggesting a potential new treatment avenue. Liver disease accounts for two million deaths annually. This is 4% of all deaths (1 out of every 25 deaths worldwide), as per the data from 2023. Liver disease is a growing global health concern. A new study suggests that a widely used diabetes medication may offer hope for patients suffering from progressive liver disease. A recent clinical trial conducted in China and published in The BMJ suggests that the type 2 diabetes drug dapagliflozin can help patients with severe liver conditions such as metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, which have limited treatment options. What does the diabetes drug do (Pic courtesy: iStock) Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT-2) inhibitor, which is widely used to treat type 2 diabetes, has been shown to improve progressive liver disease. The Chinese researchers found that the drug improved metabolic dysfunction-associated steatohepatitis (MASH), a condition where excess fat accumulates in the liver, leading to inflammation and liver fibrosis (a buildup of scar tissue). MASH affects more than 5% of adults, and it is also common (30%) in people with diabetes or obesity. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Switch to UnionBank Rewards Card UnionBank Credit Card Apply Now Undo This can progress to cirrhosis in up to 25% of individuals. Though previous studies have suggested that SGLT-2 inhibitors can improve liver fat content, liver enzymes, and liver stiffness, no trial has been carried out in patients with MASH. The study To understand the effects of dapagliflozin in patients with MASH, the researchers conducted a study. The 48-week study had 154 participants, who were diagnosed with MASH following liver biopsies at six Chinese medical centers from November 2018 to March 2023. Participants had an average age of 35, and 85% were men. Nearly half (45%0 had type 2 diabetes, and most had evidence of liver fibrosis at various stages (33% stage 1, 45% stage 2, 19% stage 3). Following an initial screening biopsy, the participants were randomly assigned to receive 10 mg of dapagliflozin or a matching placebo once daily for 48 weeks. They attended health education sessions twice a year. The researchers also recorded body weight, blood pressure, blood glucose, liver enzymes, physical activity, diet, insulin, and lipids of the participants throughout the trial. MASH improvement was defined as a decrease of at least 2 points in non-alcoholic fatty liver disease activity score (NAS) or a NAS of 3 points or less. By the end of the study, which is after 48 weeks, the researchers observed that 53% (41 of 78) participants in the dapagliflozin group showed improvement in MASH without worsening of fibrosis (defined as no increase in fibrosis stage) compared with 30% (23 of 76) in the placebo group. 23% (18 of 78) participants in the dapagliflozin group showed resolution of MASH without worsening of fibrosis, compared with 8% (6 of 76) in the placebo group. Trump Health Scare: 'Cognitive Decline' Spotted? Political Adviser's BIG Warning Amid Dementia Claim They also saw improvement in fibrosis without worsening of MASH in 45% (35 of 78) participants in the dapagliflozin group compared with 20% (15 of 76) in the placebo group. 1% (1 of 78) in the dapagliflozin group and 3% (2 of 76) in the placebo group discontinued the treatment because of adverse events. What are the experts saying Fatty liver 'Our findings indicate that dapagliflozin may affect key aspects of MASH by improving both steatohepatitis and fibrosis,' they said. They added that large-scale and long-term trials are needed to further confirm these effects. The trial was conducted in a Chinese population, which limits its broader generalisability. They also noted that with the emergence of more drugs, therapeutic decisions will likely become increasingly tailored to individual patient profiles, they write. 'Ideally, such treatments should provide cardiovascular benefit, have an established safety profile, and be accessible to broad and diverse patient populations,' they concluded. One step to a healthier you—join Times Health+ Yoga and feel the change
